We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.15B
AUM Growth
+$443M
Cap. Flow
+$176M
Cap. Flow %
2.46%
Top 10 Hldgs %
26.34%
Holding
439
New
15
Increased
206
Reduced
159
Closed
22

Top Buys

Rank Stock Value
1
PNC icon
PNC Financial Services
PNC
+$77.1M
2
JPM icon
JPMorgan Chase
JPM
+$71.1M
3
ABT icon
Abbott
ABT
+$29.4M
4
NEE icon
NextEra Energy
NEE
+$24.9M
5
EMC
EMC CORPORATION
EMC
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 16.81%
2 Consumer Staples 15.77%
3 Technology 14.57%
4 Industrials 11.84%
5 Financials 11.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GD icon
226
General Dynamics
GD
$104B
$892K 0.01%
6,477
-122
-2% -$16.6K
DHR icon
227
Danaher
DHR
$140B
$886K 0.01%
15,381
-63
-0.4% -$3.42K
CMD
228
DELISTED
Cantel Medical Corporation
CMD
$885K 0.01%
20,443
-5,500
-21% -$225K
IEMG icon
229
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$873K 0.01%
18,565
-1,420
-7% -$69.3K
MDY icon
230
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$867K 0.01%
3,285
-10
-0.3% -$2.56K
PFM icon
231
Invesco Dividend Achievers ETF
PFM
$805M
$863K 0.01%
39,782
-1,285
-3% -$27.3K
TYPE
232
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$860K 0.01%
29,825
+190
+0.6% +$5.33K
ABAX
233
DELISTED
Abaxis Inc
ABAX
$843K 0.01%
14,833
-185
-1% -$9.93K
RBA icon
234
RB Global
RBA
$17.8B
$798K 0.01%
29,664
+665
+2% +$16.5K
UNFI icon
235
United Natural Foods
UNFI
$2.91B
$788K 0.01%
10,195
+189
+2% +$13.4K
IJR icon
236
iShares Core S&P Small-Cap ETF
IJR
$112B
$771K 0.01%
13,526
+2,082
+18% +$114K
CB
237
DELISTED
CHUBB CORPORATION
CB
$768K 0.01%
7,418
+200
+3% +$19.9K
AAXJ icon
238
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.78B
$765K 0.01%
12,549
-1,750
-12% -$108K
HBI
239
DELISTED
Hanesbrands
HBI
$757K 0.01%
27,140
-1,000
-4% -$27.4K
SYNT
240
DELISTED
Syntel Inc
SYNT
$754K 0.01%
16,757
+365
+2% +$16K
JJSF icon
241
J&J Snack Foods
JJSF
$1.59B
$749K 0.01%
6,885
+130
+2% +$13.3K
WM icon
242
Waste Management
WM
$89.7B
$745K 0.01%
14,515
-350
-2% -$17K
IWR icon
243
iShares Russell Mid-Cap ETF
IWR
$57B
$739K 0.01%
17,692
-900
-5% -$36.5K
ROL icon
244
Rollins
ROL
$18.1B
$736K 0.01%
75,067
+1,570
+2% +$14.7K
EMN icon
245
Eastman Chemical
EMN
$8.39B
$734K 0.01%
9,674
-436
-4% -$34.5K
EPD icon
246
Enterprise Products Partners
EPD
$81.6B
$731K 0.01%
20,236
+2,400
+13% +$88.7K
PAGP icon
247
Plains GP Holdings
PAGP
$4.96B
$729K 0.01%
10,665
+845
+9% +$60K
TXN icon
248
Texas Instruments
TXN
$254B
$720K 0.01%
13,475
+2,030
+18% +$103K
TIS
249
DELISTED
Orchids Paper Products, Inc.
TIS
$707K 0.01%
24,290
-1,120
-4% -$30.8K
EAT icon
250
Brinker International
EAT
$9.69B
$706K 0.01%
12,033
+260
+2% +$14.2K

Similar funds

Bahl & Gaynor's Q4 2014 Portfolio in Review

As of Q4 2014, Bahl & Gaynor held 439 positions worth $7.15B, up 6.6% from $6.71B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Bahl & Gaynor's Q4 2014 filing shows 15 new, 206 increased, 159 reduced and 22 closed positions. Its largest new stake was CDK Global, Inc.: 80,991 shares worth $3.3M. The largest sale was Intel, an estimated $47.2M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Staples and Technology.

  • Bahl & Gaynor's largest Q4 2014 buy was CDK Global, Inc.: 80,991 shares worth $3.3M.
  • Bahl & Gaynor added most to PNC Financial Services in Q4 2014, an estimated $77.1M increase.
  • Bahl & Gaynor's biggest Q4 2014 reduction was Intel, cutting an estimated $47.2M.
  • Bahl & Gaynor fully exited KINDER MORGAN ENER PNTRS L.P. in Q4 2014, selling an estimated $3.52M.
  • Bahl & Gaynor's ten largest holdings make up 26% of its $7.15B portfolio in Q4 2014.
  • Bahl & Gaynor opened 15 new positions and closed 22 in Q4 2014.
  • Bahl & Gaynor's portfolio value rose 6.6% quarter-over-quarter to $7.15B.

Based on Bahl & Gaynor's 13F filing for Q4 2014, filed 4 Feb 2015.